Antares Pharma Stock Price, News & Analysis
Company Description
Antares Pharma (NASDAQ: ATRS) is a publicly traded medical instruments & supplies company in the Healthcare sector. The company has a market capitalization of $955.1M.
ATRS stock has gained 37.0% over the past year.
This page provides a comprehensive overview of ATRS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Antares Pharma (ATRS) stock. Over the past 12 months, the stock has gained 37.0%. At a market capitalization of $955.1M, ATRS is classified as a small-cap stock with approximately 170.9M shares outstanding.
Latest News
Antares Pharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, fda approval, earnings, conferences, clinical trial. View all ATRS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATRS Company Profile & Sector Positioning
Antares Pharma (ATRS) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ATRS often look at related companies in the same sector, including KESTRA MED TECHNOLOGIES LTD (KMTS), Pulse Biosciences Inc (PLSE), Embecta Corp (EMBC), Apria, Inc. (APR), and Biolife Solutions Inc (BLFS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATRS's relative position within its industry.